Peter-Paul Zwetsloot

5PUBLICATIONS
51CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 10, 2026
The Dutch cardiomyopathy registry (DCR); rationale and registry design.

|Apr 17, 2026
The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

|Mar 31, 2025
Insights From Living Myocardial Slices Into Chemotherapy-Induced Cardiotoxicity: A Novel Ex Vivo Tool to Guide Clinical Decision-Making.

Ilse R Kelters, Jort S A van der Geest, Peter-Paul M Zwetsloot

|Nov 09, 2024
Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study.

Stephan A C Schoonvelde, Isabell Wiethoff, Peter-Paul Zwetsloot

|Jan 20, 2022
Combined meta-analysis of preclinical cell therapy studies shows overlapping effect modifiers for multiple diseases.

Peter-Paul Zwetsloot, Ana Antonic-Baker, Hendrik Gremmels

Pageof 1

Frequent Collaborators

2 joint publications

Michelle Michels

1 joint publications

Ilse R Kelters

1 joint publications

Maarten Jan Cramer

1 joint publications

Niels P van der Kaaij